Mielóma multiplex: vizsgálatok itt: Egyesült Államok
297 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Boston, Hillsborough, Jacksonville, Nashville, New York, Orange, Phoenix, Rochester
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT06375044 - 1. fázisTaking peopleA Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- Where
- Atlanta, Boston, Duarte, Hackensack, Palo Alto, Portland, San Francisco, Tampa
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Kelonia Therapeutics, Inc.
See details and how to joinNCT07075185 - 2. fázisTaking peopleDasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
- Where
- Rochester
- Életkor
- 18 év and over
- People
- 44
- Run by
- Mayo Clinic
See details and how to joinNCT06940297 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
- Where
- Baton Rouge, Bethesda, Bridgeton, Farmington, Fort Myers, Los Alamitos, Macon, Nashville, Norwich, Springfield, Torrance, Whittier
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07227311 · EU 2025-523117-28-00 - No phaseNot yet taking people in Egyesült ÁllamokMM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma
- Where
- Burlington
- Életkor
- 18 év and over
- People
- 33
- Run by
- University of Vermont Medical Center
See details and how to joinNCT07783607 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Where
- Aventura, Basking Ridge, Clovis, Commack, Coral Gables, Coral Springs, Deerfield Beach, Fort Collins, Fresno, Greeley, Harrison, Hollywood, Loveland, Metairie, Miami, Middletown, Montvale, New York, Plantation, Uniondale
- Életkor
- 18 év and over
- People
- 893 worldwide
- Run by
- Pfizer
See details and how to joinNCT05020236 · EU 2023-509208-14-00 - 1/2. fázisTaking peopleSafety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
- Where
- Canton, Wilson
- Életkor
- 18 év and over
- People
- 24
- Run by
- Starton Therapeutics, Inc
See details and how to joinNCT06087653 - No phaseTaking peopleImproving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
- Where
- Omaha
- Életkor
- 19 év and over
- People
- 114
- Run by
- University of Nebraska
See details and how to joinNCT04898790 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- Where
- Boston, Bullhead City, Canton, Chapel Hill, Chattanooga, Fort Worth, Grand Rapids, Los Angeles, Nashville, Pembroke Pines, Wilson
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05714839 · EU 2022-501941-63-00 - 2. fázisTaking peopleIdentifying Effective and Cost-Conscious Maintenance Daratumumab Dosing
- Where
- Nashville
- Életkor
- 18 év to 70 év
- People
- 50
- Run by
- Eden Biltibo
See details and how to joinNCT07485647 - 3. fázisTaking peopleInobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma
- Where
- Miami
- Életkor
- 18 év and over
- People
- 450
- Run by
- CellCentric Ltd.
See details and how to joinNCT07772024 - 1/2. fázisTaking peopleA Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
- Where
- Boston, Buffalo, Columbus, Denver, Detroit, Duarte, Houston, Nashville
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06292780 · EU 2023-507809-34-00 - 2. fázisTaking peopleIMMUNOPLANT for Newly Diagnosed Multiple Myeloma
- Where
- Miami
- Életkor
- 18 év and over
- People
- 150
- Run by
- Dickran Kazandjian, MD
See details and how to joinNCT06376526 - 2. fázisTaking peopleMezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
- Where
- Buffalo
- Életkor
- 18 év and over
- People
- 28
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06627751 - Korai 1. fázisTaking peopleA Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)
- Where
- Camden
- Életkor
- 18 év and over
- People
- 20
- Run by
- Roger Strair
See details and how to joinNCT07771803 - No phaseTaking peopleDISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
- Where
- Chapel Hill
- Életkor
- 60 év and over
- People
- 500
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06296368 - 3. fázisNot yet taking people in Egyesült ÁllamokStudy of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Where
- Albany, Atlanta, Aurora, Baltimore, Baton Rouge, Chapel Hill, Charlotte, Chicago, Cincinnati, Cleveland, Columbus, Coral Gables, Dallas, Denver, Detroit, Durham, East Brunswick, Fairfax, Gilbert, Houston, Iowa City, Louisville, Milwaukee, Montgomery, Nashville, New Haven, New Hyde Park, New York, Orange, Phoenix, Portland, Puyallup, Santa Monica, Seattle, St Louis, Tampa, The Bronx, Tucson, Wichita, Winston-Salem
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07764978 - 1. fázisTaking peopleSX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Where
- Buffalo
- Életkor
- 18 év and over
- People
- 15
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06622005 - 1. fázisNot yet taking people in Egyesült ÁllamokAllogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma
- Where
- Sacramento
- Életkor
- 18 év to 65 év
- People
- 20
- Run by
- University of California, Davis
See details and how to joinNCT07759102 - No phaseCsak meghívásosMGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study
- Where
- Rochester
- Életkor
- 40 év and over
- People
- 1000
- Run by
- Mayo Clinic
See details and how to joinNCT06472830 - 4. fázisTaking peopleCosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
- Where
- Boston
- Életkor
- 18 év and over
- People
- 80
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07426484 - 1. fázisTaking peopleFeasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
- Where
- Los Angeles
- Életkor
- 18 év to 85 év
- People
- 20
- Run by
- Joshua Sasine, MD, PhD
See details and how to joinNCT05887167 - 1. fázisTaking peoplePhase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
- Where
- Milwaukee
- Életkor
- 18 év to 80 év
- People
- 30
- Run by
- Medical College of Wisconsin
See details and how to joinNCT05976555 - 1/2. fázisTaking peoplePhase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma
- Where
- Houston
- Életkor
- 18 év and over
- People
- 36
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06105554 - 2. fázisTaking peoplePre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
- Where
- Houston
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06207799